Despite the extensive utilization of radiotherapy in cancer treatments, clinicians often face
challenges in achieving desired outcomes. This is because of the existence of secondary …

Melanoma is traditionally considered to be a radioresistant tumor. However, radiotherapy
and immunotherapy latest developments might upset this radiobiological dogma …

Background We have recently shown that radiotherapy may not only be a successful local
and regional treatment but, when combined with MSCs, may also be a novel systemic …

Toll-like receptor (TLR) ligands are strongly considered immune-adjuvants for cancer
immunotherapy and have been shown to exert direct anti-cancer effects. This study was …

Despite tremendous efforts toward developing novel near‐infrared (NIR)‐absorbing
nanomaterials, improvement in therapeutic efficiency remains a formidable challenge in …

Radiotherapy is a commonly used treatment for cancer and is usually given in varying
doses. At low radiation doses relatively few cells die as a direct response to radiation but …

In this paper, we summarize published articles and experiences related to the attempt to
improve radiotherapy outcomes and, thus, to personalize the radiation treatment according …

In the past 20 years, the classic paradigm in radiobiology recognizing DNA as the main
target for the action of radiation has changed. The new paradigm assumes that both targeted …

Simple Summary Microbeams are useful tools in studies on non-target effects, such as the
radiation-induced bystander effect, and responses related to cytoplasmic irradiation. A …

Simple Summary Melanoma is the third most common type of skin cancer. Melanoma is a
heterogeneous tumor, composed of genetically divergent subpopulations. These …